Insights

Type

Select all that apply

Topic

Select all that apply

icons/content-types/article article

For many who are new to drug development, the greatest challenge is not necessarily discovering a blockbuster molecule—it’s finding a team capable of carrying that molecule through the complexities that lie between the research lab and the patien...

icons/content-types/article article

As pandemic conditions persist, the pharma industry continues to respond as rapidly as possible to bring more vaccine options to the global population. But developing one or more effective vaccines was just the first hurdle to clear. The drug industr...

icons/content-types/white paper white paper

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. The U.S. Food and Drug Administration (FDA) repor...

icons/content-types/video webinar

Presenters: Peter Talbiersky, Ph.D., Manager of Fine Chemicals Sales, Curia Listen in as our experts discuss: The importance of a green and versatile condensation reagent Safe alternative for commonly used condensation reagents like dicyclohe...

icons/content-types/article article

Though synthetic biology may be regarded as a new or emerging field of science, the concept of applying biological systems to improve chemical synthesis goes back hundreds — arguably, thousands — of years. From the earliest fermentation processes...

icons/content-types/video webinar

In this free webinar, the featured speaker will explore the key advances and critical hurdles for translating these emerging molecular biology technologies into real-world applications and commercial processes. Topics for discussion will include: a b...

icons/content-types/video webinar

Join AMRI, PCI Pharma Services, and Cardinal Health Regulatory Sciences for this three-part webinar series as we review this complex process and identify common challenges to commercialization. We will focus on what drug synthesis, clinical logistics...

icons/content-types/video webinar

The objective of this webinar is to address United States Pharmacopeia (USP) and FDA regulatory trends to demonstrate how to integrate various analytical tests into a robust program that addresses product integrity/compatibility throughout the produc...

icons/content-types/video webinar

Drug formulators should consider the physical properties of their products during pharmaceutical drug development. The physical properties of a solid drug substance are highly dependent on the solid form. It is critical to understand the solid form l...

icons/content-types/article article

From target discovery through launching a finished product to market, developing a new drug is a complex process which takes on average 10-15 years and costs around 2.6 billion dollars. Early on, this process often involves a high-throughput screenin...

icons/utility/left caret 1 icons/utility/right caret